Experience in treating drug-resistant tuberculosis in patients with HIV infection
The paper describes the experience in treating 30 patients with drug- and multidrug-resistant tuberculosis and HIV infection (median CD4+ lymphocyte count was 629 cells/µl; 8 patients received antiretroviral therapy). Only 11 (36.7%) patients effectively completed a basic treatment cycle; failing th...
Main Authors: | A. I. Gordon, I. B. Viktorova, S. A. Dolgikh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2014-12-01
|
Series: | Туберкулез и болезни лёгких |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/319 |
Similar Items
-
Factors influencing treatment efficacy in patients with multiple and extensive drug resistant tuberculosis
by: I. S. Lapshina, et al.
Published: (2020-11-01) -
The short-course chemotherapy in the treatment of multiple drug resistant tuberculosis in children with different HIV status
by: E. Yu. Zorkaltseva, et al.
Published: (2019-09-01) -
Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01) -
Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host
by: G. N. Mozhokina, et al.
Published: (2022-09-01) -
Efcacy and safety of combination therapy with bedaquiline in a multimorbid HIV positive patient with multiple drug resistant tuberculosis
by: E. M. Zhukova, et al.
Published: (2022-07-01)